ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,318Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 45

$796K Total Retail Price of All Prescriptions

Rank: 10 out of 45

409 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

19% of this provider’s 409 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

23% of this provider’s 409 patients filled at least one prescription for a schedule three drug, compared to an average of 25%.

Risky Drugs to Seniors

4% of this provider’s 10,710 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 25.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 745 435 S3 1 1
LISINOPRIL 504 353 2 2
OMEPRAZOLE 474 310 3 3
LEVOTHYROXINE SODIUM 470 359 4 5
FUROSEMIDE 409 289 5 6
SIMVASTATIN 331 256 6 4
CARVEDILOL 325 204 7 25
METFORMIN HCL 309 218 8 8
OXYCODONE HCL-ACETAMINOPHEN 282 119 S2 9 94
TRIAMTERENE-HCTZ 259 152 10 46
ATENOLOL 256 174 11 15
ATORVASTATIN CALCIUM 251 184 12 12
ZOLPIDEM TARTRATE 247 142 13 22
RANITIDINE HCL 242 136 14 16
ISOSORBIDE MONONITRATE ER 220 188 15 30
GABAPENTIN 214 134 16 9
PRAVASTATIN SODIUM 202 129 17 14
SERTRALINE HCL 198 130 18 24
AMLODIPINE BESYLATE 195 175 19 7
GLYBURIDE 192 145 R 20 55
HYDROCHLOROTHIAZIDE 183 167 21 11
LOVASTATIN 182 135 22 49
NEXIUM 181 91 23 19
CITALOPRAM HBR 173 122 24 21
METHADONE HCL 168 52 S2 25 170
METOPROLOL TARTRATE 161 146 26 10
CRESTOR 157 107 27 23
FLUOXETINE HCL 152 72 28 47
FENTANYL 150 103 S2 29 141
POTASSIUM CHLORIDE 146 75 30 13
KLOR-CON 10 143 121 31 117
CLOPIDOGREL 138 103 32 26
WARFARIN SODIUM 136 127 33 17
POLYETHYLENE GLYCOL 3350 133 126 34 53
TRAZODONE HCL 133 71 34 32
FLUTICASONE PROPIONATE 124 71 36 44
PROMETHAZINE HCL 123 36 R 37 33
DONEPEZIL HCL 122 122 38 37
LACTULOSE 120 113 39 81
METFORMIN HCL ER 111 102 40 48
DIOVAN 111 105 40 43
NAPROXEN 111 52 40 65
LOSARTAN POTASSIUM 106 66 43 27
PROAIR HFA 104 48 44 38
LISINOPRIL-HYDROCHLOROTHIAZIDE 96 42 45 29
CLONIDINE HCL 94 52 46 61
PLAVIX 92 66 47 35
CYMBALTA 90 32 48 59
RAMIPRIL 90 67 48 113
CARISOPRODOL 86 11 R 50 153
TAMSULOSIN HCL 83 62 51 34
METOPROLOL SUCCINATE 82 56 52 18
PAROXETINE HCL 82 66 52 51
NAMENDA 81 81 54 57
SYMBICORT 81 44 54 129
DOXAZOSIN MESYLATE 80 69 56 67
ADVAIR DISKUS 78 59 57 70
LANTUS 78 70 57 60
KLOR-CON M20 78 68 57 102
PREDNISONE 76 50 60 52
TRAMADOL HCL 75 38 61 20
METOLAZONE 72 57 62 221
ALPRAZOLAM 72 54 62 124
SPIRONOLACTONE 71 41 64 87
DILTIAZEM ER 70 43 65 116
ENDOCET 70 17 S2 65 90
ALLOPURINOL 69 66 67 36
CYCLOBENZAPRINE HCL 68 21 R 68 45
PROPRANOLOL HCL 65 51 69 135
METOCLOPRAMIDE HCL 65 53 69 103
OXYCODONE HCL 64 0 S2 71 99
OXYCODONE-ACETAMINOPHEN 62 40 S2 72 165
AMITRIPTYLINE HCL 62 23 R 72 42
ESTRADIOL 62 22 R 72 139
PANTOPRAZOLE SODIUM 60 38 75 31
BUPROPION HCL SR 60 21 75 171
ALENDRONATE SODIUM 59 46 77 62
COMBIVENT 58 43 78 109
NYSTATIN 58 52 78 194
BUSPIRONE HCL 55 37 80 73
SPIRIVA 52 26 81 54
CIPROFLOXACIN HCL 52 44 81 85
TORSEMIDE 51 34 83 253
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 7, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.